This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Oncology, Other  • Endocrine Surgery  • Surgical Oncology  • Hepatobiliary Surgery  • Liver/ Biliary Tract/ Pancreatic Diseases  • Alert me on articles by topic

Ching-Ning Chong, MB, ChB; Kit-Fai Lee, FRCS, FRCSEd; John Wong, FRCSEd; Paul Bo San Lai, FRCSEd, MD
Author Affiliations: Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

Arch Surg. 2006;141:831.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

A 22-year-old woman who was previously healthy came to us with a self-palpable left upper quadrant abdominal mass that she had for 6 months. She was otherwise totally asymptomatic. Physical examination revealed a 6-cm nontender mass in the left hypochondrium. Blood test results including complete blood cell counts, renal and liver functions, amylase level, carcinoembryonic antigen level, and -fetoprotein level were all normal. Plain abdominal radiography revealed a calcified mass lesion. Contrast computed tomography of the abdomen was subsequently performed, and it showed a pancreatic tail lesion (Figure 1). Incidentally, another 5-cm lesion was noted at the right lobe of the liver. A whole-body positron emission tomographic scan was performed, and it showed hypermetabolic, heterogeneously enhancing masses at both the pancreatic tail and the right lobe of the liver. No other . . . [Full Text of this Article]

What Is the Diagnosis?

RELATED ARTICLE

Image of the Month—Diagnosis
Arch Surg. 2006;141(8):832.
EXTRACT | FULL TEXT